Cash flow from operating activities CFO
0.16 B
Last period CFO ,USD
161%
CFO has increased in 5 years
What is CFO ?
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
See also Horizon Therapeutics
Company Analysis
HZNP valuation, rating, competitors, insights and company profile
Eyestock Rating
HZNP financial analysis by Eyestock methodology
Valuation
HZNP valuation using historical relative method
Financials
HZNP revenue, earnings, ROE, ROIC and other financials
Statements
HZNP Income Statements, Balance Sheet and Cash Flow Statements
Dividends
HZNP dividend yield and annual dividend
What is CFO ?
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
What is CFO of Horizon Therapeutics ?
Horizon Therapeutics`s CFO for the period ended 2023-06-30 is 0.16 B USD